Joachim Kreuzburg, left, CEO of Sartorius, poses with Incheon mayor Park Nam-choon at the G-Tower on Thursday. The meeting was held to discuss the $300 million investment pledge made to build a biopharmaceutical raw material plant in Songdo
Joachim Kreuzburg, left, CEO of German-based biotech company Sartorius, poses with Incheon mayor Park Nam-choon after a meeting at the G-Tower in Yeonsu District, Incheon, on Thursday. The meeting was held to discuss the $300 million investment pledge made in November for Sartorius to build a biopharmaceutical raw material plant in Songdo, Incheon. The plant will manufacture cell culture media, membrane filters and other raw materials. [INCHEON FREE ECONOMIC ZONE]
![Joachim Kreuzburg, left, CEO of German-based biotech company Sartorius, poses with Incheon mayor Park Nam-choon after a meeting at the G-Tower in Yeonsu District, Incheon, on Thursday. The meeting was held to discuss the $300 million investment pledge made in November for Sartorius to build a biopharmaceutical raw material plant in Songdo, Incheon. The plant will manufacture cell culture media, membrane filters and other raw materials. [INCHEON FREE ECONOMIC ZONE]](https://img1.daumcdn.net/thumb/R658x0.q70/?fname=https://t1.daumcdn.net/news/202111/25/koreajoongangdaily/20211125185256974pbku.jpg)